GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Other Current Liabilities

ME Therapeutics Holding (XCNQ:METX) Other Current Liabilities : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Other Current Liabilities?

ME Therapeutics Holding's other current liabilities for the quarter that ended in Feb. 2024 was C$0.00 Mil.

ME Therapeutics Holding's annual other current liabilities increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$-0.00 Mil) and increased from Aug. 2022 (C$-0.00 Mil) to Aug. 2023 (C$0.00 Mil).


ME Therapeutics Holding Other Current Liabilities Historical Data

The historical data trend for ME Therapeutics Holding's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Other Current Liabilities Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Other Current Liabilities
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Other Current Liabilities Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


ME Therapeutics Holding Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines